Product Images Tamsulosin Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 55154-2142 by Cardinal Health 107, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
0.4mg bag label - 262d5283 99e2 6377 e063 6394a90a60b5 00
Tamsulosin Hydrochloride Capsules, USP 0.4mg is a medication indicated for a specific dosage, typically found in packages of 10 capsules. The product contains Tamsulosin Hydrochloride, USP 0.4 mg per capsule. It is recommended to refer to the package insert for detailed prescribing information, precautions, and warnings. The storage conditions should be maintained between 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). This medication is only available through prescription (RX ONLY). The packaging is not child-resistant and is designed for institutional use. It is essential to keep this and all medications out of children's reach and to not use the product if the blister is torn or broken. The product is distributed by American Health Packaging and is from NDC # 68382132, Zydus Pharmaceuticals USA Inc. Pharmacies should dispense this medication with patient information. There is additional distribution through Cardinal Health, based in Dublin, Ohio.*
Figure 1 - Figure 1
Figure 2A - Figure 2A
This text appears to be a table showing the mean change in treatment over different time points. It includes data on the duration of treatment in weeks and the number of participants at each time point. The data seems to be related to the effects of a specific treatment or medication.*
Figure 2B - Figure 2B
This data appears to represent a study on the mean change in response to different treatments over a certain duration of weeks. The treatments mentioned are 0.4 mg, 0.8 mg, and placebo. The numbers in parentheses represent the sample sizes for each treatment group. The study includes a total of 857 participants.*
Figure 3A - Figure 3A
Mean Change in treatment of -0.08 mg, 0.04 mg, and Placebo was evaluated using a duration of treatment for weeks as presented in the data.*
Figure 3B - Figure 3B
This is a list of measurements and treatment information possibly related to medical data. The values provided seem to include changes in measurements, treatment details such as dosage levels, and the duration of treatment in weeks. The text mentions different treatment groups involving drugs or placebo and also includes codes related to the specific treatment and duration details.*
Structural Formula - Structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
